Sort news by
12/11/2014 - 9:31am

Isis Pharmaceuticals, Inc. has initiated a Phase I/II trial for ISIS-DMPKrx in patients affected by myotonic dystrophy type 1 (DM1).

12/10/2014 - 2:18pm

In 2013, MDF launched a significant effort to increase the number of support groups for families living with DM, and we now have 14 groups across the US and Canada. Join us in celebrating the people who have brought these groups to life!

12/09/2014 - 3:36pm

Dr. Tetsuo Ashizawa, MD, has focused his career on the search for DM treatments and care for those affected. His multi-disciplinary, patient-centric approach to care moves DM research out of the lab and into his clinic at the University of Florida.

11/05/2014 - 3:04pm

Each year just before the holidays, we reach out to our community to ask for your support. Your contributions help us continue our efforts to find care and a cure for DM. Read our annual appeal to see what's on the horizon for 2015!

10/22/2014 - 12:56pm

This year’s oversold conference, held last month in Washington, DC, was arguably the most successful conference to date with unparalleled participation from researchers, industry and federal agency representatives and a number of programmatic “firsts.”